Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with investigational icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICONIC-LEAD Topline ...
Key findings from the ICONIC-LEAD study: At Week 24, nearly half of patients treated with icotrokinra achieved completely clear skin - 46% reached IGA 0 and 40% reached PASI 100. 1 Nearly two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results